Skip to main content

Table 3 Rate of patients with high PeCDF level in each population with three symptoms

From: Cutaneous symptoms such as acneform eruption and pigmentation are closely associated with blood levels of 2,3,4,7,8-penta-chlorodibenzofurans in Yusho patients, using data mining analysis

 

Symptom 1

Symptom 2

Symptom 3

Proportion of patients with the symptoms

Proportion of patients with high PeCDF (> 50 pg/g lipids)

1

uric acid (high)

Sex <female>

History of acneform eruptions <present>

0.0755

0.8889

2

History of Yusho in and after 1968 <present>

cholesterol (high)

Subjective symptoms, etc. <present>

0.0692

0.8485

3

uric acid (high)

1-hour erythrocyte sedimentation rate (elevated)

History of acneform eruptions <present>

0.0545

0.8462

4

uric acid (high)

1-hour erythrocyte sedimentation rate (elevated)

Sex <female>

0.0650

0.8387

5

Subjective symptoms, etc. <present>

Sex <female>

History of pigmentation <present>

0.0755

0.8333

6

uric acid (high)

Sex <female>

History of pigmentation <present>

0.0629

0.8333

7

cholesterol (high)

Heaviness of head/headache <present>

Subjective symptoms, etc. <present>

0.0503

0.8333

8

History of Yusho in and after 1968 <present>

Subjective symptoms, etc. <present>

Second quartile age

0.0503

0.8333

9

History of Yusho in and after 1968 <present>

uric acid (high)

1-hour erythrocyte sedimentation rate (elevated)

0.0713

0.8235

10

1-hour erythrocyte sedimentation rate (elevated)

Subjective symptoms, etc. <present>

Sex <female>

0.0713

0.8235